Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure

  1. Isabel Rodriguez-Barraquer  Is a corresponding author
  2. Emmanuel Arinaitwe
  3. Prasanna Jagannathan
  4. Moses R Kamya
  5. Phillip J Rosenthal
  6. John Rek
  7. Grant Dorsey
  8. Joaniter Nankabirwa
  9. Sarah G Staedke
  10. Maxwell Kilama
  11. Chris Drakeley
  12. Isaac Ssewanyana
  13. David L Smith
  14. Bryan Greenhouse
  1. University of California, San Francisco, United States
  2. Infectious Diseases Research Collaboration, Uganda
  3. Stanford University, United States
  4. Makerere University College of Health Sciences, Uganda
  5. Infectious Diseases Resarch Collaboration, Uganda
  6. London School of Hygiene and Tropical Medicine, United Kingdom
  7. University of Washington, United States

Abstract

Fundamental gaps remain in our understanding of how immunity to malaria develops. We used detailed clinical and entomological data from parallel cohort studies conducted across the malaria transmission spectrum in Uganda to quantify the development of immunity against symptomatic P. falciparum as a function of age and transmission intensity. We focus on: anti-parasite immunity (i.e; ability to control parasite densities) and anti-disease immunity (i.e; ability to tolerate higher parasite densities without fever). Our findings suggest a strong effect of age on both types of immunity, not explained by cumulative-exposure. They also show an independent effect of exposure, where children living in moderate/high transmission settings develop immunity faster as transmission increases. Surprisingly, children in the lowest transmission setting appear to develop immunity more efficiently than those living in moderate transmission settings. Anti-parasite and anti-disease immunity develop in parallel, reducing the probability of experiencing symptomatic malaria upon each subsequent P. falciparum infection.

Data availability

All the data used for these analyses as well as the R code used to reproduce the main study findings are available at https://github.com/isabelrodbar/immunity. Complete data from the 3 cohort studies are available at the CliEpiDB website (https://clinepidb.org/ce/app/record/dataset/DS_0ad509829e).

Article and author information

Author details

  1. Isabel Rodriguez-Barraquer

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    For correspondence
    isabel.rodriguez-barraquer@ucsf.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6784-1021
  2. Emmanuel Arinaitwe

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  3. Prasanna Jagannathan

    Department of Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6305-758X
  4. Moses R Kamya

    Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  5. Phillip J Rosenthal

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. John Rek

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  7. Grant Dorsey

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Joaniter Nankabirwa

    Infectious Diseases Resarch Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  9. Sarah G Staedke

    London School of Hygiene and Tropical Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Maxwell Kilama

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  11. Chris Drakeley

    London School of Hygiene and Tropical Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4863-075X
  12. Isaac Ssewanyana

    Infectious Diseases Research Collaboration, Kampala, Uganda
    Competing interests
    The authors declare that no competing interests exist.
  13. David L Smith

    Institute of Health Metrics and Evaluation, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4367-3849
  14. Bryan Greenhouse

    Department of Medicine, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Institutes of Health (2U19AI089674)

  • Isabel Rodriguez-Barraquer
  • Emmanuel Arinaitwe
  • Prasanna Jagannathan
  • Moses R Kamya
  • Phillip J Rosenthal
  • John Rek
  • Grant Dorsey
  • Joaniter Nankabirwa
  • Sarah G Staedke
  • Maxwell Kilama
  • Chris Drakeley
  • Isaac Ssewanyana
  • David L Smith
  • Bryan Greenhouse

Bill and Melinda Gates Foundation (OPP1110495)

  • David L Smith

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The study protocol was reviewed and approved by the Makerere University School of Medicine Research and Ethics Committee (Identification numbers 2011-149 and 2011-167, the Uganda National Council for Science and Technology, , the London School of Hygiene and Tropical Medicine Ethics Committee (Identification numbers 5943 and 5944), the Durham University School of Biological and Biomedical Sciences Ethics Committee (PRISM Entomology Uganda), and the University of California, San Francisco, Committee on Human Research (Identification numbers 11-05539 and 11-05995) and the Uganda National Council for Science and Technology (Identification numbers HS350 and HS-1019).. All parents/guardians were asked to provide written informed consent at the time of enrollment.

Copyright

© 2018, Rodriguez-Barraquer et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,646
    views
  • 622
    downloads
  • 100
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Isabel Rodriguez-Barraquer
  2. Emmanuel Arinaitwe
  3. Prasanna Jagannathan
  4. Moses R Kamya
  5. Phillip J Rosenthal
  6. John Rek
  7. Grant Dorsey
  8. Joaniter Nankabirwa
  9. Sarah G Staedke
  10. Maxwell Kilama
  11. Chris Drakeley
  12. Isaac Ssewanyana
  13. David L Smith
  14. Bryan Greenhouse
(2018)
Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure
eLife 7:e35832.
https://doi.org/10.7554/eLife.35832

Share this article

https://doi.org/10.7554/eLife.35832

Further reading

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Amanda C Perofsky, John Huddleston ... Cécile Viboud
    Research Article

    Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here, we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997—2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection ynamics, presumably via heterosubtypic cross-immunity.